Table 4 Pretreatment, treatment, and outcome
Variables | Moderate (n = 33) | Severe (n = 37) | p |
|---|---|---|---|
Pretreatment | 10 (30.3) | 18 (48.6) | 0.118 |
Antihistamine | 10 | 18 | |
Hydrocortisone | 10 | 18 | |
Treatment | |||
H1 blocker | 33 (100.0) | 34 (91.9) | 0.242 |
H2 blocker | 23 (69.7) | 23 (62.2) | 0.507 |
β2 agonist nebulizer | 2 (6.1) | 2 (5.4) | 1.000 |
Steroid | 25 (75.8) | 32 (86.5) | 0.249 |
Hydrocortisone | 16 | 22 | |
Methylprednisolone | 14 | 18 | |
Dexamethasone | 0 | 0 | |
Epinephrine | 11 (33.3) | 37 (100.0) | <0.001 |
Intramuscular | 5 | 28 | |
Subcutaneous | 3 | 3 | |
Intravenous | 3 | 6 | |
Disposition | 0.004 | ||
Discharge | 26 (78.8) | 19 (51.4) | |
Admission | 4 (12.1) | 17 (45.9) | |
AMA discharge | 3 (9.1) | 1 (2.7) | |
Death | 0 | 0 | |